Literature DB >> 9796662

Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients.

M G van Kraaij1, A W Dekker, E Peters, A Fluit, L F Verdonck, M Rozenberg-Arska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9796662     DOI： 10.1007/bf01708627

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  14 in total

1.  Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.

Authors:  R R Muder; C Brennen; A M Goetz; M M Wagener; J D Rihs
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

2.  Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.

Authors:  M Cruciani; R Rampazzo; M Malena; L Lazzarini; G Todeschini; A Messori; E Concia
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

3.  Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.

Authors:  M López-Brea; T Alarcón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

4.  Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

Authors:  A Cometta; T Calandra; J Bille; M P Glauser
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

5.  Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.

Authors:  K Sato; Y Inoue; T Fujii; H Aoyama; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 6.  Bacterial resistance to quinolones: mechanisms and clinical importance.

Authors:  J S Wolfson; D C Hooper
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

7.  Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

Authors:  J Carratalá; A Fernández-Sevilla; F Tubau; M Callis; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

8.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

9.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

Authors:  N Akopyanz; N O Bukanov; T U Westblom; S Kresovich; D E Berg
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 10.  Mechanisms of resistance to the 4-quinolone antibacterial agents.

Authors:  G C Crumplin
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790
View more
  4 in total

1.  Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Authors:  W V Kern; K Klose; A S Jellen-Ritter; M Oethinger; J Bohnert; P Kern; S Reuter; H von Baum; R Marre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 2.  Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Authors:  Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

3.  Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital.

Authors:  A van Belkum; W Goessens; C van der Schee; N Lemmens-den Toom; M C Vos; J Cornelissen; E Lugtenburg; S de Marie; H Verbrugh; B Löwenberg; H Endtz
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

4.  Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.

Authors:  Pudjo H Widjajanto; Sumadiono Sumadiono; Jacqueline Cloos; Ignatius Purwanto; Sutaryo Sutaryo; Anjo Jp Veerman
Journal:  J Blood Med       Date:  2013-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.